Funded Tech Companies

Numab Therapeutics

Numab Therapeutics is a biopharmaceutical venture, located in Horgen. Financial backing was provided by HBM Healthcare Investments, BVF Partners and BlackRock.

Company Overview

Contact Information

Company Background Information

Overview

We are developing multi-specific antibody-based immunotherapies for inflammation and cancer. Reproducible plug-and-play therapeutic design process using proprietary platforms ?-Cap� and MATCH� puts Numab in a unique position to overcome historical drug discovery barriers and build a pipeline of new and important medicines aimed to maximize patient benefits. Diverse research pipeline spans multiple therapeutic areas and creates the opportunity for the next generation of first-in-class and best-in-class medicines.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/10/2025

Financing History

Management Team

Title

Name

Email & Social

Chairman

Carlo Incerti

        

Chief Executive Officer

David Urech

        

Chief Financial Officer

Roland Helfenstein

        

Chief Operating Officer

Sebastian Meyer

        

Vice President

Tea Gunde

        

Vice President

Martin Stern

        

Vice President

Elmar vom Baur

        

Vice President

Stefan Warmuth

        

VP - Bus. Development

Mireia Gómez-Angelats

        

VP - General Counsel

James Singleton

        

VP - R & D

Daniel Snell

        

Company Investors

• HBM Healthcare Investments
• BVF Partners
• BlackRock
• Forbion Capital Partners
• RTW Investments
• Octagon Capital
• Novo Holdings
• Cormorant Asset Management (Bihua Chen)

Browse more funded tech companies:

NUMA Group | Numares Health

Share this article

About Our VC Funding Database

The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary